4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes
Artículo
Open/ Download
Publication date
2004-02-04Metadata
Show full item record
Cómo citar
Villalobos, Claudio A.
Cómo citar
4-Bromo-2,5-dimethoxyphenethylamine (2C-B) and structurally related phenylethylamines are potent 5-HT2A receptor antagonists in Xenopus laevis oocytes
Author
Abstract
1 We recently described that several 2-(2,5-dimethoxy-4-substituted phenyl)ethylamines (PEAs),
including 4-I¼2C-I, 4-Br¼2C-B, and 4-CH3¼2C-D analogs, are partial agonists at 5-HT2C
receptors, and show low or even negligible intrinsic efficacy at 5-HT2A receptors. These results raised
the proposal that these drugs may act as 5-HT2 antagonists.
2 To test this hypothesis, Xenopus laevis oocytes were microinjected with the rat clones for 5-HT2A or
5-HT2C receptors. The above-mentioned PEAs and its 4-H analog (2C-H) blocked the 5-HT-induced
currents at 5-HT2A, but not at the 5-HT2C receptor, revealing 5-HT2 receptor subtype selectivity. The
5-HT2A receptor antagonism required a 2-min preincubation to attain maximum inhibition.
3 All PEAs tested shifted the 5-HT concentration–response curves to the right and downward. Their
potencies varied with the nature of the C(4) substituent; the relative rank order of their 5-HT2A
receptor antagonist potency was 2C-I42C-B42C-D42C-H.
4 The present results demonstrate that in X. laevis oocytes, a series of 2,5-dimethoxy-4-substituted
PEAs blocked the 5-HT2A but not the 5-HT2C receptor-mediated responses. As an alternative
hypothesis, we suggest that the psychostimulant activity of the PEAs may not be exclusively associated
with partial or full 5-HT2A receptor agonism
Patrocinador
This
research was partially funded by the Center for Cell Regulation and
Pathology (FONDAP, Grant 1398001). The Millennium Institutes for
Fundamental and Applied Biology (MIFAB) and for Advanced
Studies in Cell Biology and Biotechnology (CBB) also contributed to
the funding of this research. Grant DICYT 020091SB provided
additional funds.
Quote Item
British Journal of Pharmacology, Vol. 141, p. 1167–1174, 2004.
Collections